These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1353356)

  • 1. Probable resistance to vecuronium involving the 17-hydroxy metabolite.
    Cozanitis DA
    Br J Anaesth; 1992 Jul; 69(1):110-1. PubMed ID: 1353356
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat.
    Marshall IG; Gibb AJ; Durant NN
    Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vecuronium neuromuscular block in patients with malignant obstructive jaundice.
    Baraka A
    Can J Anaesth; 1994 Aug; 41(8):759-60. PubMed ID: 7923531
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat.
    Bencini AF; Houwertjes MC; Agoston S
    Br J Anaesth; 1985 Aug; 57(8):789-95. PubMed ID: 2861840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of isoflurane on the duration of neuromuscular block induced by a single dose of vecuronium bromide].
    Amiot JF; Palacci JH; Bouju P; Roessler JG
    Cah Anesthesiol; 1988 Sep; 36(5):349-52. PubMed ID: 2903790
    [No Abstract]   [Full Text] [Related]  

  • 6. Pipecuronium-induced prolongation of vecuronium neuromuscular block.
    Smith I; White PF
    Br J Anaesth; 1993 Apr; 70(4):446-8. PubMed ID: 8098952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated recovery from combined atracurium-vecuronium neuromuscular block.
    Stirt JA
    Br J Anaesth; 1989 Jun; 62(6):697-9. PubMed ID: 2568849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of large dose of vecuronium with pancuronium for prolonged neuromuscular blockade.
    Rørvik K; Husby P; Gramstad L; Vamnes JS; Bitsch-Larsen L; Koller ME
    Br J Anaesth; 1988 Aug; 61(2):180-5. PubMed ID: 2901270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vecuronium-induced neuromuscular block during xenon or sevoflurane anaesthesia in humans.
    Nakata Y; Goto T; Morita S
    Br J Anaesth; 1998 Feb; 80(2):238-40. PubMed ID: 9602592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of carbamazepine on the dose-response relationship of vecuronium.
    Whalley DG; Ebrahim Z
    Br J Anaesth; 1994 Jan; 72(1):125-6. PubMed ID: 7906533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuromuscular blockade using vecuronium in dermatomyositis].
    Mair P; Mitterschiffthaler G; Hohlböck E
    Anaesthesist; 1989 Nov; 38(11):626-8. PubMed ID: 2576854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged weakness and vecuronium.
    Scott VL; Freeman JA; DeWolf AM
    Ann Intern Med; 1993 Apr; 118(7):570; author reply 571. PubMed ID: 8095131
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenytoin-induced resistance to vecuronium.
    Platt PR; Thackray NM
    Anaesth Intensive Care; 1993 Apr; 21(2):185-91. PubMed ID: 8100123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to vecuronium in a patient with facioscapulohumeral muscular dystrophy.
    Nitahara K; Sakuragi T; Matsuyama M; Dan K
    Br J Anaesth; 1999 Sep; 83(3):499-500. PubMed ID: 10655933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experience of vecuronium bromide 10 mg preparation].
    Katsumata N; Shiraishi H; Suzuki H
    Masui; 1991 May; 40(5):801-6. PubMed ID: 1677050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isobolographic and dose-response analysis of the interaction between pipecuronium and vecuronium.
    Naguib M; Abdulatif M
    Br J Anaesth; 1993 Oct; 71(4):556-60. PubMed ID: 7903151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged neuromuscular paralysis with vecuronium in a patient with polymyositis.
    Flusche G; Unger-Sargon J; Lambert DH
    Anesth Analg; 1987 Feb; 66(2):188-90. PubMed ID: 2880531
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent paralysis in critically ill patients after long-term administration of vecuronium.
    Segredo V; Caldwell JE; Matthay MA; Sharma ML; Gruenke LD; Miller RD
    N Engl J Med; 1992 Aug; 327(8):524-8. PubMed ID: 1353252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is vecuronium a long-acting neuromuscular blocking agent in neonates and infants?
    Meretoja OA
    Br J Anaesth; 1989 Feb; 62(2):184-7. PubMed ID: 2564279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged vecuronium-induced neuromuscular blockade in children.
    Harwood TN; Moorthy SS
    Anesth Analg; 1989 Apr; 68(4):534-6. PubMed ID: 2564751
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.